E-Newsletter - July 2022
New Committee Leadership


Saad Z. Usmani, MD, MBA, FACP, has been appointed Chair of the Alliance Myeloma Committee. Dr. Usmani is an internationally recognized physician leader, clinical and translational investigator focused on multiple myeloma and related plasma cell disorders. He has led the clinical development of several novel immunotherapeutics and small molecules for multiple myeloma. His clinical/translational research focuses on the prognostic role of novel imaging in multiple myeloma, identifying mechanisms and biomarkers of resistance to novel agents in high risk multiple myeloma, and investigating novel agents that can circumvent the drug resistance mechanisms in high risk multiple myeloma.




For other articles in this issue of the Alliance E-news Newsletter, see below: